|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.4850 CAD | -3.00% |
|
+1.04% | +6.59% |
| 06-03 | PharmaCorp Rx Initiated at Outperform, $0.70 Price Target at Raymond James | MT |
| 06-01 | Earnings Flash (PCRX.V) PharmaCorp Reports Q1 Revenue $7.2M, Up 79.4% YoY | MT |
Main competitors
| Revenues (Y-1) | Net Margin (Y-1) | EBIT Margin (Y-1) | ROE (Y-1) | ROA (Y-1) | Leverage (Y-1) | ||
|---|---|---|---|---|---|---|---|
 | 15.24M | -7.09% | - | - | - | -6.91x | |
| 10.5B | 7.32% | 5.37% | 9.32% | 7.03% | -7.43x | |
| 4.22B | 4.68% | 4.83% | 9.28% | 7.01% | -5.08x | |
| 7.09B | 5.15% | 7.73% | 10.6% | 12% | -1.05x | |
| 3.49B | 6.87% | 10.04% | 14.98% | 6.06% | -1.29x | |
| 2.71B | 6.77% | 9.78% | 49.2% | 14.9% | -0.5x | |
| 2.72B | 8.14% | 9.08% | 30.3% | 12.4% | 0.71x | |
| 3.93B | 4.49% | 7.41% | 17.16% | 4.67% | -0.84x | |
| 1.45B | 3.4% | 5.02% | - | - | - | |
| 7.34B | 3.55% | 6.24% | 17.17% | - | -0.31x | |
| 2.69B | 2.29% | 4.33% | 21.52% | 6.1% | 0.96x | |
| 3.45B | -1.28% | -0.41% | -7.99% | -3.4% | 5.65x | |
| 718M | 2.45% | 3.87% | 9.06% | - | -0.92x | |
| 1.8B | 4.78% | 6.95% | 23.15% | 6.84% | 2.62x | |
| 2.48B | 1.52% | 2.44% | 3.57% | 3.39% | -1.3x | |
| 784M | 3.17% | 4.21% | 31.35% | - | 0.65x | |
| 1.38B | 3.52% | 4.81% | 14.2% | 8.21% | 1.77x | |
| Average | 3.34B | 3.51% | 5.73% | 16.86% | 7.1% | -0.83x | |
| Weighted average by Cap. | 5.79B | 5.5% | 6.26% | 15.21% | 8.01% | -3.01x |
- Stock Market
- Stocks
- PCRX Stock
- Sector PharmaCorp Rx Inc.
- Financial comparisons
Select your edition
All financial news and data tailored to specific country editions
